Lamothe Jeffrey G.
SEC CIK 1679967 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| APVO | Aptevo Therapeutics Inc. | SVP, CFO | 961 | — | — | 10 | 2022-01-29 | 2026-08-06 |
Most active insiders at APVO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grant Grady III | Dir | $20.1K | — |
| 2 | Kwon SoYoung | SVP, GC, BD, Corp Affairs | — | — |
| 3 | Huebner Dirk | SVP, CMO | — | — |
| 4 | Kunz Barbara Lopez | Dir | — | — |
| 5 | Lamothe Jeffrey G. | Pres, CEO, Dir | — | — |
| 6 | Niederhuber John | Dir | — | — |
| 7 | White Marvin L | Executive COB, Dir | — | — |
| 8 | Taylor Daphne | SVP, CFO | — | — |
| 9 | Abdun-Nabi Daniel | Dir | — | — |
| 10 | Harsanyi Zsolt | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 21:38 | 2026-08-06 | APVO | Aptevo Therapeutics Inc. | Lamothe Jeffrey G. | Pres, CEO, Dir | M - OptEx | — | +961 | 961 | New | — |
| D | 2025-07-21 | 2025-07-17 | APVO | Aptevo Therapeutics Inc. | Lamothe Jeffrey G. | EVP, COO | M - OptEx | — | +5 | 6 | +500% | — |
| DM | 2025-03-04 | 2025-03-02+ | APVO | Aptevo Therapeutics Inc. | Lamothe Jeffrey G. | EVP, COO | M - OptEx | — | +5 | 36 | +16% | — |
| DM | 2024-08-09 | 2024-08-08 | APVO | Aptevo Therapeutics Inc. | Lamothe Jeffrey G. | EVP, COO | M - OptEx | — | +314 | 894 | +54% | — |
| DM | 2024-03-05 | 2024-03-02+ | APVO | Aptevo Therapeutics Inc. | Lamothe Jeffrey G. | EVP, COO | M - OptEx | — | +9,167 | 33.8K | +37% | — |
| D | 2024-01-30 | 2024-01-28 | APVO | Aptevo Therapeutics Inc. | Lamothe Jeffrey G. | EVP, COO | M - OptEx | — | +1,833 | 28.3K | +7% | — |
| DM | 2023-08-10 | 2023-08-08 | APVO | Aptevo Therapeutics Inc. | Lamothe Jeffrey G. | EVP, COO | M - OptEx | — | +13.8K | 26.5K | +109% | — |
| D | 2023-03-07 | 2023-03-03 | APVO | Aptevo Therapeutics Inc. | Lamothe Jeffrey G. | EVP, COO | M - OptEx | — | +3,666 | 12.7K | +41% | — |
| D | 2023-01-30 | 2023-01-29 | APVO | Aptevo Therapeutics Inc. | Lamothe Jeffrey G. | CFO | M - OptEx | — | +1,834 | 9,026 | +26% | — |
| D | 2022-02-01 | 2022-01-29 | APVO | Aptevo Therapeutics Inc. | Lamothe Jeffrey G. | SVP, CFO | M - OptEx | — | +1,833 | 7,192 | +34% | — |
Purchase Sale Sale after option exercise All abbreviations